CytoDome Inc. provides implantable devices for the enhancement of distribution and uptake of therapeutic and diagnostic substances for treating CNS disorders. It offers small implantable devices for the treatment of various disorders, including primary and metastases brain cancers, Parkinson's disease, ischemia, and chronic pain. The company focuses on application, such as Glioblastoma Multiforme, a form of primary brain cancer.